多种药物出口商AcrB的结构揭示了一个近接的多站点药物绑定口袋
Ryosuke Nakashima1, Keisuke Sakurai, Seiji Yamasaki
1Department of Cell Membrane Biology, Institute of Scientific and Industrial Research, Osaka University, Ibaraki, Osaka 567-0047, Japan.
Nature
|November 29, 2011
概括
多种药物运输器AcrB有两个不同的药物绑定口袋. 高分子量抗生素连续使用两个口袋,而低分子量药物绕过第一个口袋.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 生物化学 生物化学
背景情况:
- AcrB是格拉姆阴性细菌中关键的多药物载体,对抗生素耐受性至关重要.
- AcrB 作为 AcrA 和 TolC 的三方复合体的一部分.
- 之前的研究已经确定了一些药物的结合部位在氨集群区域.
研究的目的:
- 为了确定AcrB与高分子质量药物里芬素和红素结合的晶体结构.
- 阐明药物结合机制,并在AcrB.内确定不同的结合口袋.
主要方法:
- 采用X射线晶体学,获取了AcrB的结构,该结构与里芬素和红红素复合.
- 对晶体结构的分析揭示了药物结合点和相互作用.
主要成果:
- 沿着AcrB的分子内通道确定了两个离散的多站点结合口袋:一个近端口袋和一个远端口袋 (氨酸团区域).
- 高分子质量的药物依次结合:首先在接入状态下与近端口袋结合,然后通过围静机制与远端口袋结合.
- 低分子量药物绕过近端口袋,直接与远端口袋结合.
结论:
- AcrB拥有两个不同的绑定口袋,解释了其广泛的基板识别.
- 涉及子域运动的环静电机制促进了高分子质量药物的运输.
- 了解AcrB的结合机制,可以了解抗生素耐药性和药物开发.
相关概念视频
ABC Transporters: Exporter
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer
ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Multi-pass Transmembrane Proteins and β-barrels
In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...


